ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Group” or “Advanced”) ISIN Code: ZAE000189049 JSE Code: AVL Distribution of Disposal Circular and notice of General Meeting 1. Introduction Shareholders are referred to the detailed terms and cautionary announcement released on SENS on 23 December 2022 and the Firm Intention Announcement released on 30 January 2023, in which shareholders were advised that PresMed BidCo Pty Limited entered into a binding Share Sale Agreement (“SSA”) on 23 December 2022 (“Signature Date”) to purchase 100% of the shares within PresMed Australia Pty Limited (“PMA”), the Australian subsidiary of Advanced Health, from Advanced Health and other PMA shareholders (the “Transaction” or “Disposal”). PresMed BidCo Pty Limited is an entity owned by ICG Asia Pacific Fund IV (a USD 1.1 billion fund managed by London Stock Exchange listed Intermediate Capital Group plc (“ICG”)) and a consortium of management and medical shareholders (the “Consortium”). Pursuant to the Transaction, Advanced Health will dispose of 635,274 issued ordinary PMA shares (representing its entire equity interest, being 56.44% of PMA’s shares for a total transaction consideration of AUD45.2 million (approximately ZAR522.0 million). 2.Distribution of Disposal Circular Shareholders are advised that the circular providing shareholders with relevant information regarding the Disposal (the “Disposal Circular”) was distributed to shareholders today, 24 February 2023. The Disposal Circular is available on the Company website: www.advancedhealth.co.za Notice of General Meeting Notice is hereby given that the General Meeting (“GM”) of ordinary shareholders will be held at 10:00 on Tuesday, 28 March 2023, at Building 3, 2nd Floor, Walker Creek Office Park, 90 Florence Ribeiro Avenue, Muckleneuk, Pretoria, to transact the business as stated in the Notice of General Meeting forming part of the Disposal Circular. The salient dates and times regarding the Disposal and GM meeting are set out below: 2023 Record date to determine which shareholders are eligible to receive this Circular Friday, 17 February Posting of this Circular including notice of general meeting to shareholders Friday, 24 February Last day to trade in Advanced Health ordinary shares in order to be recorded in the register to Tuesday, 14 March vote at the general meeting Voting record date to vote at the general meeting Friday, 17 March Last day to lodge forms of proxy in respect of general meeting by 10h00 on Friday, 24 March General meeting to be convened at 10h00 on Tuesday, 28 March Last date and time for Advanced Health Shareholders to give notice to Advanced Health objecting Tuesday, 28 March to the Disposal in terms of section 164(3) of the Companies Act, by 10:00 on Publication of results of general meeting on SENS Tuesday, 28 March ACTION If the Disposal is approved by the Shareholders at the General Meeting, the following dates assume that neither Court approval nor the review of the Disposal is required and will be confirmed in the finalisation announcement to be released simultaneously with the results of the General Meeting. Last day for Advanced Health Shareholders who voted against the Disposal to require Advanced 5 Business Days after the General Health to seek court approval for the Disposal in terms of section 115(3)(a) of the Companies Act, Meeting, currently anticipated to if at least 15% of the total votes of Advanced Health Shareholders at the General Meeting were be Wednesday, 5 April exercised against the Disposal on 10 Business Days after the General Meeting, currently Last day for Advanced Health Shareholders who voted against the Disposal to apply to the court for anticipated to be Wednesday, 12 a review of the Disposal in terms of section 115(3)(b) of the Companies Act on April Should votes against or objections to the Disposal be lodged as contemplated in paragraph 22 of this Circular, the dates set out below will not be applicable, and a further finalisation announcement will be released in due course. Tuesday, 28 March Finalisation date expected to be on Tuesday, 28 March Finalisation date announcement expected to be released on SENS on Monday, 3 April Expected operative date of the Disposal: TRP issues compliance certificate in terms of the Act Notes: 1) The above dates and times may be subject to amendment. Any such amendment will be released on SENS and published in the South African press. 2) Unless otherwise indicated, all times are South African times; 3) Any Form of Proxy (yellow) not delivered by 10h00 on Friday, 24 March 2023 may be handed to the chairman of the general meeting immediately before the appointed proxy exercises any of the shareholder rights at the general meeting; 4) The dates have been determined based on certain assumptions regarding the dates by which certain Advanced Health Shareholder and regulatory approvals will be obtained and that no court approval or review of the Disposal will be required. If the relevant dates change and the dates set out above are therefore impacted, details of the relevant change will be released on SENS and published in the South African press; and 5) If the general meeting is adjourned or postponed, forms of proxy submitted for the initial general meeting will remain valid. Shareholders are encouraged to view the notice of GM and the Disposal Circular on the Company’s website. Johannesburg 24 February 2023 Designated Advisor Grindrod Bank Limited 2|P ag e